PHASE IV

We find that a product launch is merely a milestone in drug development, albeit an important one, rather than a mark of the end of the development process.

We understand that Phase IV is an important phase of drug development, to know the real-world effectiveness of a drug as evaluated in an observational, non-interventional trial in a naturalistic setting which complements the efficacy data that emanates from pre-marketing Randomized Clinical Trials (RCT).

Our association with potential investigator sites and the experienced study team will help in undertaking different Phase 4 studies, including PMS, Registry, Non-interventional, Drug Utilization studies as well as, Adverse Event Monitoring, and many more.